Health And Medicine

A research team led by Josh Peterson, M.D., MPH, assistant professor of Biomedical Informatics and Medicine, and John Graves, Ph.D., assistant professor of Preventive Medicine, will study the cost-effectiveness of testing patients’ risk of adverse gene-drug interactions. Read More

A group of Vanderbilt researchers has used laser technology and a custom-built multiphoton microscope to distinguish breast cancer subtypes and determine if specific therapies are working against the cancer cells in as little as two days. Read More

The hormone relaxin may offer a novel approach for treating diet-induced insulin resistance. Read More

Magnesium and vitamin D appear to work together to reduce risk of death from cardiovascular disease and colorectal cancer. Read More

Importin alpha 5, a member of a family of proteins that “shuttle” other proteins into the nucleus, is a potential new target for drugs to treat inflammatory diseases. Read More

Travis Ladner, a third-year student at the Vanderbilt University School of Medicine, has been selected for a 2013 Congress of Neurological Surgeons (CNS) student fellowship award. The award is presented to a medical student every year from a national pool of applicants. Read More

Vanderbilt University’s Center for Interdisciplinary Health Workforce Studies has been awarded $2.2 million from the Gordon and Betty Moore Foundation to address nursing workforce issues that may impede future health care. Read More

Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies. Read More

A recent Vanderbilt study shows a significant number of patients are entering I.C.U.’s throughout the world with no evidence of cognitive — brain related issues, but are leaving with symptoms associated with mild Alzheimer’s or Traumatic Brain Injury. Barb Cramer has more. Read More

Patients treated in intensive care units across the globe enter their medical care with no evidence of cognitive impairment but often leave with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer’s disease (AD) that persist for at least a year, according to a Vanderbilt University Medical Center study published today in the New England Journal of Medicine. Read More

While the Framingham Heart Study is often referenced throughout the halls of academia, few know its origin or can fully appreciate the contribution it has made to the understanding and prevention of cardiovascular disease. Read More

Death of oligodendrocytes, the cells that make myelin, appears to be an early event in the development of multiple sclerosis. Read More

Vanderbilt researchers used existing genome-wide association study datasets to identify gene interactions that contribute to tooth decay. Read More

A panel of metabolites – small molecules that are part of metabolic processes – that are unique to macular degeneration will shed light on the disease and aid diagnosis. Read More

Molecular characterization of pre-cancerous changes in cells lining the stomach could point to lesions with a greater risk of progression to cancer. Read More

The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units. Read More

Jeffrey Sosman, M.D., professor of Medicine, Ingram Chair for Cancer Research and director of the Vanderbilt Melanoma Program, was named one of the Hottest Scientific Researchers of the last year by Thomas Reuters Science Watch. Read More

Recent scientific findings have raised the fear that young athletes may fare worse after sustaining a sports-related concussion than older athletes. Read More

Women with access to group prenatal care had improved birth outcomes, including longer gestational periods and higher birth weight, in a study conducted by researchers at Vanderbilt’s Peabody Research Institute. Read More

Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring. Read More